Patents by Inventor Naohito Aoki
Naohito Aoki has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 9029110Abstract: A functional microbially fermented tea extract containing a novel polyphenol derivative and a method for producing the same are provided. A functional microbially fermented tea extract containing various extracts and a novel polyphenol derivative is produced by subjecting, to an extraction treatment, a microbially fermented tea leaf obtained by culturing one species selected from Aspergillus sp. (PK-1), Aspergillus oryzae (NBRS 4214) sp. (AO-1), Aspergillus awamori (NBRS 4122) sp. (SK-1), and Eurotium sp. (KA-1) with a tea leaf. Furthermore, for example, a functional fermented tea extract enriched with a novel polyphenol derivative is produced.Type: GrantFiled: September 17, 2010Date of Patent: May 12, 2015Assignees: Kabushiki Kaisha Riverson, Saga University, Nagasaki Prefectural University CorporationInventors: Teruyoshi Yanagita, Kanji Ishimaru, Takashi Tanaka, Kazunori Koba, Hitoshi Miyazaki, Naohito Aoki, Denbei Kawamura
-
Patent number: 8558016Abstract: A novel substance exhibiting physiologically active effects is produced from a tea leaf. A novel polyphenol derivative is produced, for example, by subjecting a microbially fermented tea leaf obtained by culturing Aspergillus sp. (PK-1) with a tea leaf, to an extraction treatment.Type: GrantFiled: September 17, 2010Date of Patent: October 15, 2013Assignees: Kabaushiki Kaisha Riverson, Saga UniversityInventors: Teruyoshi Yanagita, Kanji Ishimaru, Takashi Tanaka, Kazunori Koba, Hitoshi Miyazaki, Naohito Aoki, Denbei Kawamura
-
Publication number: 20120220789Abstract: A novel substance exhibiting physiologically active effects is produced from a tea leaf. A novel polyphenol derivative is produced, for example, by subjecting a microbially fermented tea leaf obtained by culturing Aspergillus sp. (PK-1) with a tea leaf, to an extraction treatment.Type: ApplicationFiled: September 17, 2010Publication date: August 30, 2012Applicants: SAGA UNIVERSITY, KABUSHIKI KAISHA RIVERSONInventors: Teruyoshi Yanagita, Kanji Ishimaru, Takashi Tanaka, Kazunori Koba, Hitoshi Miyazaki, Naohito Aoki, Denbei Kawamura
-
Publication number: 20120220650Abstract: A functional microbially fermented tea extract containing a novel polyphenol derivative and a method for producing the same are provided. A functional microbially fermented tea extract containing various extracts and a novel polyphenol derivative is produced by subjecting, to an extraction treatment, a microbially fermented tea leaf obtained by culturing one species selected from Aspergillus sp. (PK-1), Aspergillus oryzae (NBRS 4214) sp. (AO-1), Aspergillus awamori (NBRS 4122) sp. (SK-1), and Eurotium sp. (KA-1) with a tea leaf. Furthermore, for example, a functional fermented tea extract enriched with a novel polyphenol derivative is produced.Type: ApplicationFiled: September 17, 2010Publication date: August 30, 2012Applicants: KABUSHIKI KAISHA RIVERSON, NAGASAKI PREFECTURAL UNIVERSITY CORPORATION, SAGA UNIVERSITYInventors: Teruyoshi Yanagita, Kanji Ishimaru, Takashi Tanaka, Kazunori Koba, Hitoshi Miyazaki, Naohito Aoki, Denbei Kawamura
-
Publication number: 20090249513Abstract: The present invention relates to a method for expressing and accumulating a low-molecular peptide in plant seeds; a vector therefore; and a plant transformed with the vector. In the present invention, an intended peptide composed of 3 to 40 amino acid residues is expressed and accumulated in seeds of a plant by transforming the plant with a fusion protein expression vector comprising a gene encoding a member of the glutelin multigene family and two or more copies of a gene encoding the intended peptide ligated downstream of the gene under the control of a promoter.Type: ApplicationFiled: March 1, 2006Publication date: October 1, 2009Applicant: NATIONAL UNIVERSITY CORPORATION NAGOYA UNIVERSITYInventors: Tsukasa Matsuda, Naohito Aoki, Fujio Hashizume, Shingo Hino, Misako Kakehashi
-
Publication number: 20080051556Abstract: Nucleic acid molecules encoding full length PTP20, PCP-2, BDP1, mCLK2, mCLK3, mCLK4, and SIRP polypeptides, portions of such nucleic acid molecules, nucleic acid vectors containing such nucleic acid molecules, recombinant cells containing such nucleic acid vectors, polypeptides purified from such recombinant cells, antibodies to such polypeptides, and methods of identifying compounds that bind such polypeptides or abrogate their interactions with natural binding partners. Methods for diagnosing abnormal conditions in an organism with PTP20, PCP-2, BDP1, mCLK2, mCLK3, mCLK4, and SIRP related molecules or compounds. PTP20, PCP-2, BDP1, mCLK2, mCLK3, mCLK4, or SIRP polypeptides, nucleic acids encoding such polypeptides, cells, tissues and animals containing such nucleic acids, antibodies to such polypeptides, assays utilizing such polypeptides, and methods relating to all of the foregoing.Type: ApplicationFiled: June 16, 2005Publication date: February 28, 2008Inventors: Axel Ullrich, Naohito Aoki, Yeong Woong Kim, Hong Yang Wang, Zhengjun Chen, Oliver Nayler, Alexei Kharitonenkov
-
Patent number: 7074589Abstract: Nucleic acid molecules encoding full length PTP20, PCP-2, BDP1, mCLK2, mCLK3, mCLK4, and SIRP polypeptides, portions of such nucleic acid molecules, nucleic acid vectors containing such nucleic acid molecules, recombinant cells containing such nucleic acid vectors, polypeptides purified from such recombinant cells, antibodies to such polypeptides, and methods of identifying compounds that bind such polypeptides or abrogate their interactions with natural binding partners. Methods for diagnosing abnormal conditions in an organism with PTP20, PCP-2, BDP1, mCLK2, mCLK3, mCLK4, and SIRP related molecules or compounds. PTP20, PCP-2, BDP1, mCLK2, mCLK3, mCLK4, or SIRP polypeptides, nucleic acids encoding such polypeptides, cells, tissues and animals containing such nucleic acids, antibodies to such polypeptides, assays utilizing such polypeptides, and methods relating to all of the foregoing.Type: GrantFiled: June 17, 1997Date of Patent: July 11, 2006Assignee: Max-Planck-Gesellschaft zur Forderung der Wissenschaften E.V.Inventors: Axel Ullrich, Naohito Aoki, Yeong Woong Kim, Hong Yang Wang, Zhengjun Chen, Oliver Nayler, Alexei Kharitonenkov
-
Patent number: 6482605Abstract: The present invention relates to a novel polypeptide, PTP20, and to nucleic acid molecules encoding the polypeptide . The invention also relates to nucleic acid molecules encoding portions of the phosphatase, nucleic acid vectors containing PTP20 related nucleic acid molecules, recombinant cells containing such nucleic acid vectors, polypeptides purified from such recombinant cells, antibodies to such polypeptides, and methods of identifying compounds that bind PTP20 or abrogate its interactions with natural binding partners. Also disclosed are methods for diagnosing abnormal conditions in an organism with PTP20 related molecules or compounds.Type: GrantFiled: October 29, 1999Date of Patent: November 19, 2002Assignee: Sugen, Inc.Inventors: Naohito Aoki, Axel Ullrich
-
Publication number: 20020169303Abstract: Nucleic acid molecules encoding full length PTP20, PCP-2, BDP1, mCLK2, mCLK3, mCLK4, and SIRP polypeptides, portions of such nucleic acid molecules, nucleic acid vectors containing such nucleic acid molecules, recombinant cells containing such nucleic acid vectors, polypeptides purified from such recombinant cells, antibodies to such polypeptides, and methods of identifying compounds that bind such polypeptides or abrogate their interactions with natural binding partners. Methods for diagnosing abnormal conditions in an organism with PTP20, PCP-2, BDP1, mCLK2, mCLK3, mCLK4, and SIRP related molecules or compounds. PTP20, PCP-2, BDP1, mCLK2, mCLK3, mCLK4, or SIRP polypeptides, nucleic acids encoding such polypeptides, cells, tissues and animals containing such nucleic acids, antibodies to such polypeptides, assays utilizing such polypeptides, and methods relating to all of the foregoing.Type: ApplicationFiled: March 5, 2002Publication date: November 14, 2002Applicant: Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften, E.V.Inventors: Axel Ullrich, Naohito Aoki, Yeong Woong Kim, Hong Yang Wang, Zhengjun Chen, Oliver Nayler, Alexei Kharitonenkov
-
Patent number: 6004791Abstract: The present invention relates to a novel polypeptide, PTP20, and to nucleic acid molecules encoding the polypeptide. The invention also relates to nucleic acid molecules encoding portions of the phosphatase, nucleic acid vectors containing PTP20 related nucleic acid molecules, recombinant cells containing such nucleic acid vectors, polypeptides purified from such recombinant cells, antibodies to such polypeptides, and methods of identifying compounds that bind PTP20 or abrogate its interactions with natural binding partners. Also disclosed are methods for diagnosing abnormal conditions in an organism with PTP20 related molecules or compounds.Type: GrantFiled: October 16, 1997Date of Patent: December 21, 1999Assignee: Max-Planck-Gesellschaft zur Forderung der Wissenschaften E.V.Inventors: Naohito Aoki, Axel Ullrich